TPST · Company research

Tempest Therapeutics, Inc. Common Stock (TPST): Valuation Analysis

Available valuation snapshots and ratios; unavailable metrics remain blank.

RESEARCH CONTEXT

Understand the numbers

Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.

1records availableHealthcare

Valuation Analysis data

Database-backed records only

1 rows
valuation datepricemarket capenterprise valuepeforward pepegprice salesprice bookprice fcf
Oct 8, 20260.7875$8,857,869.817052869.8079————10.7759973332116788—

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.